Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Value Health ; 26(4): 528-535, 2023 04.
Artículo en Inglés | MEDLINE | ID: mdl-36442833

RESUMEN

OBJECTIVES: The objective of this study was to analyze the accessibility of psychotropic medicine in developing countries based on the availability, price, and affordability indicators to create international evidence to guide the development of policies on the accessibility of medicines. METHODS: This study included 5 types of psychotropic medicines listed in the 22nd edition of the World Health Organization Model List of Essential Medicines published by the World Health Organization in 2021. Derived from 84 surveys in 59 countries, this study summarizes the availability, price, and affordability of originator branded drugs (OBs) and lowest-price generic drugs (LPGs) in the public and private sectors and compares them based on income levels in different countries. RESULTS: The average availability of psychotropic medicine was 45% in low- and lower-middle-income countries (LLMICs) compared with 49% in high- and upper-middle-income countries (HUMICs) whereas the availability of LPGs was higher than that of OBs in all country groups. The average patient price for OBs and LPGs was 94.0 and 23.2, respectively, and the overall patient price of psychotropic medicine in LLMICs was higher than that in HUMICs. The affordability of psychotropic medicine in LLMICs was lower than that in HUMICs. CONCLUSIONS: Psychotropic medicines in lower-middle-income countries have lower availability, a higher average patient price, and lower average affordability than in HUMICs, which requires lower-middle-income countries to take effective and various measures to improve the accessibility of psychotropic medicine.


Asunto(s)
Medicamentos Esenciales , Accesibilidad a los Servicios de Salud , Humanos , Países en Desarrollo , Estudios Transversales , Organización Mundial de la Salud , Encuestas y Cuestionarios
2.
Materials (Basel) ; 15(5)2022 Feb 25.
Artículo en Inglés | MEDLINE | ID: mdl-35268983

RESUMEN

Ti is widely used as a material for orthopedic implants. As rapid and effective osseointegration is a key factor for the successful application of implants, biologically inert Ti materials start to show inherent limitations, such as poor surface cell adhesion, bioactivity, and bone-growth-inducing capabilities. Surface modification can be an efficient and effective approach to addressing the biocompatibility, mechanical, and functionality issues of the various Ti implant materials. In this study, we have overviewed more than 140 papers to summarize the recent progress in the surface modification of Ti implants by physical and/or chemical modification approaches, aiming at optimizing their wear resistance, biocompatibility, and antimicrobial properties. As an advanced manufacturing technology for Ti and Ti alloys, additive manufacturing was particularly addressed in this review. We also provide an outlook for future research directions in this field as a contribution to the development of advanced Ti implants for biomedical applications.

3.
Spectrochim Acta A Mol Biomol Spectrosc ; 254: 119655, 2021 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-33744702

RESUMEN

Metal-organic framework (MOFs), also known as porous coordination polymers (PCPs), is a new kind of crystalline porous materials, which has received extensive attention in the past few decades. As a new type of sensing material, MOFs stand out from many other traditional fluorescence sensors because of its crystal characteristics, structural diversity, stable porosity and adjustable functional characteristics. In this work, the bi-functional building block containing aromatic carboxylic acid and triazole moieties, namely 3-(1H-1,3,4-triazol-1-yl) benzoic acid, was selected as the linker to synthesize {[Cd(µ5-L)⋅I}n (1, HL = 3-(1H-1,3,4-triazol-1-yl)benzoic acid) by hydrothermal method with transition CdII metal centers. Firstly, the preliminary characterization of 1 was carried out by means of PXRD, FT-IR, and then the UV and fluorescence tests were conducted to study the fluorescence properties of 1. The crystal structure analysis indicates that CdII is the center and the ligand is bridged to form a two-dimensional porous structure. In addition, 1 has good selectivity for Fe3+ and Cr2O72-, meanwhile, it has high detection sensitivity (Ksv quenching efficiency for Fe3+: 1.2 × 104 M-1 and Cr2O72- 1.85 × 104 M-1) and low detection limit (Fe3+: 19.21 µM and Cr2O72-: 12.46 µM). The results of photoluminescence test show that 1 can detect cations and anions with high sensitivity, resist the interference of other ions, and have good reusability. As far as we know, 1 is the first example of ultra-stable two-dimensional (2D) Cadmium (II) microporous coordination material as a fluorescence sensor for Fe3+ and Cr2O72-.

4.
Spectrochim Acta A Mol Biomol Spectrosc ; 247: 119092, 2021 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-33120122

RESUMEN

In recent years, a new type of micro-porous material, namely metal organic framework material, has received more and more attention from many basic and industrial fields because these materials possess unique advantages. In this work, through the powerful sonochemical preparation method, a three-dimensional cluster-based CdII-MOFs, {[Cd(abtz)2(H2O)2]·(ClO4)2·H2O}n (1, abtz = 1-(4-aminobenzyl)-1H-1,2,4-triazole) can be quickly synthesized in the facile ultrasonic method. Powder X-ray diffraction (PXRD) measurement confirms that these bulky samples 1 (synthesized on different ultrasonic powers and ultrasonic time conditions) were pure. In addition, ultrasonic chemical time and irradiation power did not change the structure of composites materials 1. SEM and morphological changes of 1 in the ultrasonic synthesis are also determined. Moreover, 1 exhibits good stability, the structure of 1 can be maintained not just in various solvents, and in aqueous environments with pH values from 2 to 12. Photo-luminescent experiment also reveals that complex 1 has the excellent application prospect as highly sensitive sensing material for the biomarker DPA (2,6-pyridine dicarboxylic acid) and 5-HT (5-hydroxytryptamine) through the photo-luminescence "turn-on" and "turn-off" effect, respectively. Further photo-luminescent measurements also show that different ultrasonic powers and ultrasonic time can effectively induce fluorescent sensing enhancement for biomarkers DPA and 5-HT based on the water stable clustered-based cadmium(II) coordination framework.


Asunto(s)
Biomarcadores , Cadmio , Serotonina , Ultrasonido , Biomarcadores/análisis , Serotonina/análisis , Agua
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA